Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kura Oncology, Inc. | 100,000 | reported | 22 Jan 2019 | tx 5+403,250 |
| Turning Point Therapeutics, Inc. | 27,979 | reported | 09 Feb 2022 | tx 37+242,423−146,551 |
| AMBIT BIOSCIENCES CORP | 0 | reported | 10 Nov 2014 | tx 5+103,502−169,502 |
| SGX PHARMACEUTICALS, INC. | 0 | reported | 20 Aug 2008 | tx 17+143,250−198,102 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2022 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 16,283 | 0.00 USD | |
| 09 Feb 2022 | SALE | Turning Point Therapeutics, Inc. | 669 | 36.30 USD | |
| 09 Feb 2022 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 58,600 | 0.00 USD | deriv |
| 30 Aug 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 10,000 | 17.00 USD | |
| 30 Aug 2021 | SALE | Turning Point Therapeutics, Inc. | 10,000 | 80.00 USD | |
| 30 Aug 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 15 Jun 2021 | SALE | Turning Point Therapeutics, Inc. | 5,666 | 75.94 USD | |
| 15 Jun 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 15,000 | 17.00 USD | |
| 15 Jun 2021 | SALE | Turning Point Therapeutics, Inc. | 2,700 | 77.37 USD | |
| 15 Jun 2021 | SALE | Turning Point Therapeutics, Inc. | 6,634 | 77.82 USD | |
| 15 Jun 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 06 May 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 5,882 | 17.00 USD | |
| 06 May 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 5,882 | 0.00 USD | deriv |
| 08 Mar 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 20,000 | 17.00 USD | |
| 08 Mar 2021 | SALE | Turning Point Therapeutics, Inc. | 500 | 103.30 USD | |
| 08 Mar 2021 | SALE | Turning Point Therapeutics, Inc. | 700 | 111.69 USD | |
| 08 Mar 2021 | SALE | Turning Point Therapeutics, Inc. | 9,419 | 109.89 USD | |
| 08 Mar 2021 | SALE | Turning Point Therapeutics, Inc. | 4,571 | 110.77 USD | |
| 08 Mar 2021 | SALE | Turning Point Therapeutics, Inc. | 4,810 | 109.09 USD | |
| 08 Mar 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 08 Feb 2021 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 6,483 | 0.00 USD | |
| 08 Feb 2021 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 29,175 | 0.00 USD | deriv |
| 01 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 500 | 125.38 USD | |
| 01 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 3,313 | 124.41 USD | |
| 02 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 400 | 126.66 USD |